Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion
NCT00160199
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class
Conditions
Secondary Amenorrhea
Interventions
DRUG:
PROMETRIUM® 300 mg
DRUG:
PROMETRIUM® 400 mg
Sponsor
Solvay Pharmaceuticals